π£ VC round data is live. Check it out!
- Public Comps
- Med Life
Med Life Valuation Multiples
Discover revenue and EBITDA valuation multiples for Med Life and similar public comparables like Ramsay SantΓ©, Almoosa Health, Mitra Keluarga, Ardent Health and more.
Med Life Overview
About Med Life
Med Life SA is a healthcare provider in Romania. The Company's activity resides in the performance of healthcare services activities through medical centres with national coverage. It is engaged in the provision of rendering of medical services, rental of medical facilities and acquisition of materials and commodities. The company provides medical service through Hyper clinics in Arad, Bucharest, Braila, Brasov, Cluj, Constanta, Craiova, Galati, Iasi, Oradea, Ploiesti, Sibiu and Timisoara; Clinics, hospitals located in Bucharest, Arad, Sibiu, Brasov, Cluj and Ploiesti, Laboratories, Pharmacies and Dental Clinics.
Founded
1996
HQ

Employees
7.6K
Website
Sectors
Financials (LTM)
EV
$2B
Valuation Multiples
Start free trialMed Life Financials
Med Life reported last 12-month revenue of $752M and EBITDA of $109M.
In the same LTM period, Med Life generated $109M in EBITDA and $12M in net income.
Revenue (LTM)
Med Life P&L
In the most recent fiscal year, Med Life reported revenue of $602M and EBITDA of $86M.
Med Life is profitable as of last fiscal year, with gross margin of 82%, EBITDA margin of 14%, and net margin of 1%.
Financial data powered by Morningstar, Inc.
Med Life Stock Performance
Med Life has current market cap of $1B, and enterprise value of $2B.
Market Cap Evolution
Med Life's stock price is $2.60.
Med Life share price decreased by 5.7% in the last 30 days, and increased by 73.4% in the last year.
Med Life has an EPS (earnings per share) of $0.01.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2B | $1B | 0.0% | -5.7% | -15.5% | 73.4% | $0.01 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialMed Life Valuation Multiples
Med Life trades at 2.4x EV/Revenue multiple, and 16.2x EV/EBITDA.
EV / Revenue (LTM)
Med Life Financial Valuation Multiples
As of May 24, 2026, Med Life has market cap of $1B and EV of $2B.
Med Life has a P/E ratio of 118.2x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Med Life Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Med Life Margins & Growth Rates
Med Life grew revenue by 22% and EBITDA by 22% in the last fiscal year.
In the most recent fiscal year, Med Life reported gross margin of 82%, EBITDA margin of 14%, and net margin of 1%.
Med Life Margins
Med Life Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Med Life Operational KPIs
Med Life's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.
Med Life's Rule of 40 is 21% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Med Life's Rule of X is 29% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Med Life Competitors
Med Life competitors include Ramsay SantΓ©, Almoosa Health, Mitra Keluarga, Ardent Health, Agilon Health, Aevis Victoria, Burjeel Holdings, Netcare, Spire Healthcare Group and Terveystalo.
Most Med Life public comparables operate across Hospitals & Clinics.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 0.9x | β | 8.4x | β | |||
| 4.3x | 4.0x | 17.0x | (17.6x) | |||
| 3.7x | 3.6x | 9.7x | 9.4x | |||
| 0.5x | 0.5x | 5.5x | 5.6x | |||
| 0.2x | 0.2x | (4.2x) | (7.2x) | |||
| 1.7x | 1.9x | 24.3x | 21.0x | |||
| 1.5x | 1.5x | 7.6x | 7.8x | |||
| 1.2x | 1.2x | 6.2x | 6.2x | |||
This data is available for Pro users. Sign up to see all Med Life competitors and their valuation data. Start Free Trial | ||||||
Med Life M&A Activity
Med Life has acquired 7 companies to date.
Last acquisition by Med Life was on October 28th 2024. Med Life acquired Routine Med for undisclosed valuation.
Latest Acquisitions by Med Life
| Description | Routine Med is a medical services provider offering lab tests, consultations, and online booking in Romania. Bucharest-based Routine Med operates clinics in multiple cities with specialties in radiology, cardiology, and dermatology. The platform integrates telehealth for remote appointments and results delivery via mobile app. Established in 2019, it partners with private insurers for corporate wellness programs serving over 50,000 patients annually. | Antares Clinic is a Romania-based medical facility providing over 1000 laboratory tests alongside diagnostic imaging and clinical investigations. Located in Bucharest, the clinic delivers comprehensive services in pathology, biochemistry, hematology, and specialized diagnostics to support patient care and treatment decisions across general and specialized medicine. | Provita is a Bucharest-based diagnostic and treatment center offering services in cardiology, neurology, orthopedics, and imaging diagnostics. Located in Romania's capital, it operates a 24/7 emergency unit and specialized clinics for endoscopy, dermatology, and physiotherapy. Established in 2010, the facility serves over 50,000 patients yearly with advanced equipment from Siemens and GE Healthcare. | β | |
| HQ Country | |||||
| HQ City | Tulcea | Piatra Neamt | Bucharest | β | |
| Deal Date | 28 Oct 2024 | 1 Jul 2024 | 5 Oct 2022 | 12 Sep 2022 | |
| Valuation | undisclosed | undisclosed | undisclosed | undisclosed | |
| EV/Revenue | |||||
| EV/EBITDA | |||||
This data is available for Pro users. Sign up to see all Med Life acquisitions and their M&A valuation multiples. Start Free Trial | |||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Med Life
| When was Med Life founded? | Med Life was founded in 1996. |
| Where is Med Life headquartered? | Med Life is headquartered in Romania. |
| How many employees does Med Life have? | As of today, Med Life has over 7K employees. |
| Who is the CEO of Med Life? | Med Life's CEO is Mihail Marcu. |
| Is Med Life publicly listed? | Yes, Med Life is a public company listed on Bucharest Stock Exchange. |
| What is the stock symbol of Med Life? | Med Life trades under M ticker. |
| When did Med Life go public? | Med Life went public in 2016. |
| Who are competitors of Med Life? | Med Life main competitors include Ramsay SantΓ©, Almoosa Health, Mitra Keluarga, Ardent Health, Agilon Health, Aevis Victoria, Burjeel Holdings, Netcare, Spire Healthcare Group, Terveystalo. |
| What is the current market cap of Med Life? | Med Life's current market cap is $1B. |
| What is the current revenue of Med Life? | Med Life's last 12 months revenue is $752M. |
| What is the current revenue growth of Med Life? | Med Life revenue growth (NTM/LTM) is 8%. |
| What is the current EV/Revenue multiple of Med Life? | Current revenue multiple of Med Life is 2.4x. |
| Is Med Life profitable? | Yes, Med Life is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Med Life? | Med Life's last 12 months EBITDA is $109M. |
| What is Med Life's EBITDA margin? | Med Life's last 12 months EBITDA margin is 15%. |
| What is the current EV/EBITDA multiple of Med Life? | Current EBITDA multiple of Med Life is 16.2x. |
| What is the current FCF of Med Life? | Med Life's last 12 months FCF is $16M. |
| What is Med Life's FCF margin? | Med Life's last 12 months FCF margin is 2%. |
| What is the current EV/FCF multiple of Med Life? | Current FCF multiple of Med Life is 112.9x. |
| How many companies Med Life has acquired to date? | As of May 2026, Med Life has acquired 7 companies. |
| What was the largest acquisition by Med Life? | None of the M&A deals Med Life has completed have disclosed valuations. |
| What companies Med Life acquired? | Med Life acquired Routine Med, SanoPass, Opticristal, Antares Clinic, SfatulMedicului.ro, Provita, and Valdi Medica. |
| In how many companies Med Life has invested to date? | Med Life hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Med Life
Lists including Med Life
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.
